Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 1Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6Head & Neck 3Other 1CNS 1

Conditions

Head and Neck Neoplasms 3Pain 1Nasopharyngeal Carcinoma 1Breakthrough Pain 1Agnosia 1

Interventions

Cisplatin 5lenvatinib 4Fentanyl 4Morphine 3Fluorouracil 3Docetaxel 3trametinib 2selpercatinib 2pralsetinib 2pembrolizumab 2nimotuzumab 2larotrectinib 2dabrafenib 2cabozantinib 2anlotinib 2Thyrotropin Alfa 2Saline Solution 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Norepinephrine 2Metformin 2Indocyanine Green 2Gabapentin 2Cinacalcet 2Cetuximab 2Carboplatin 2Benzydamine 2Acetaminophen 2xiaojin wan 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Morphine × Head & Neck × Clear all
NCT04246697 2023-08-18

Multimodal Pain Study in Free Flap Patients

University of Kansas Medical Center

Phase 4 Completed
30 enrolled
Head & Neck

Agnosia, Head and Neck Neoplasms

NCT04292990 2020-07-29

Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients

Jiangmen Central Hospital

Phase 4 Unknown
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Pain

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed
20 enrolled
Head & Neck

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡